Genmab reported DKK2.16B in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Amarin AMRN:US USD 95.02M 62.25M
Amgen AMGN:US USD 3.91B 504M
Artemis Alpha ATS:LN GBP 833K 39K
AstraZeneca AZN:LN USD 9.74B 495M
Bayer BAYN:GR EUR 10.08B 2.57B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Exelixis EXEL:US USD 329.12M 6.6M
Fresenius Medical Care FME:GR EUR 4.62B 208M
Galapagos GLPG:NA EUR 185.62M 38.28M
Genmab GEN:DC DKK 2.16B 241M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Hikma Pharmaceutical HIK:LN USD 964M 118M
Immunogen IMGN:US USD 92.8M 17.59M
Insmed INSM:US USD 195.43M 41.89M
Merck MRK:GR EUR 4.57B 181M
Novartis NOVN:VX USD 10.67B 183M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Roche Holding ROG:VX 20.75B 3.26B
Seattle Genetics SGEN:US USD 703.1M 72.49M
William Demant Holding WDH:DC DKK 7.91B 340M